Hormone therapy after risk-reducing surgery in patients with BRCA1/BRCA2 mutation: evaluation of potential benefits and safety

SUMMARY Women with mutations in the BRCA 1 and 2 genes are at increased risk for ovarian and breast cancer and therefore candidates for risk-reducing surgery, including salpingo-oophorectomy and mastectomy. Risk-reducing salpingo-oophorectomy (RRSO) is considered the most effective prophylactic meas...

Full description

Bibliographic Details
Main Author: Silva Filho,Agnaldo Lopes da (author)
Other Authors: Carvalho,Gabriella Martins (author), Sena,Larissa Cristelli de (author), Gomes,Lívia Passini Guimarães (author), Valério,Marcos Flávio Habib (author), Martins,Raíssa Isabelle Leão (author), Cândido,Eduardo Batista (author)
Format: article
Language:eng
Published: 2020
Subjects:
Mutation
Estrogen replacement therapy
Salpingostomy
Ovariectomy
Salpingo-oophorectomy
Breast neoplasms
Ovarian neoplasms
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302020000801134
Country:Brazil
Oai:oai:scielo:S0104-42302020000801134

Internet

http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302020000801134

Similar Items